Table 4 Summary of Mortality Data
Study | Deaths Treatment | Deaths Control | Notes |
|---|---|---|---|
Groothuis 1993 (RSV-IGIV) | 3 | 0 | No deaths due to RSV or RSV-IGIV |
PREVENT 1997 (RSV-IGIV) | 5 | 2 | No deaths due to RSV or RSV-IGIV |
Simoes 1998 (RSV-IGIV) | 13 | 13 | 2 deaths in treatment group & 5 in control group due to respiratory causes |
Subramanan 1998 (Palivizumab) | 0 | 1 | Disseminated adenovirus |
IMPACT-RSV 1998 (Palivizumab) | 4 | 5 | 2 deaths in treatment group occurred during RSV hospitalization |
Feltes 2003 (Palivizumab) | 21 | 27 | 2 deaths in treatment group and 4 deaths in control group due to RSV |